Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Uni-Charm Indonesia Tbk. (UCID)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Uni-Charm Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Uni-Charm Indonesia Tbk. diperdagangkan di Rp515 (kapitalisasi pasar 2,14 T, volume 24 jam 2,52 jt). Perbedaan utamanya: Uni-Charm Indonesia Tbk. jauh lebih besar — sekitar 20,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | UCID | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 2,14 T |
Volume | — | 2,52 jt |
Lot | — | 25,17 rb |
Perputaran | — | 1,3 M |
Harga Rata-rata | — | 518,01 |
Nilai Transaksi | — | 1,3 M |
Harga Ekuilibrium Indikatif | — | 515 |
Volume Ekuilibrium Indikatif | — | 6 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Uni-Charm Indonesia Tbk.
PT Uni-Charm Indonesia Tbk (the Company) was established based on Notarial Deed No. 37 dated 5 June 1997 of Linda Herawati S.H. The Company commenced its commercial operation in February 1998. The Company and its Subsidiary (the Group) operates under Unicharm Group. The ultimate parent of the Group is Unicharm Corporation, domiciled in Japan.
Selengkapnya di halaman UCID →
